Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Soares, Maria Vd and Gomez, Virginia Escamilla and Azevedo, Rita and Pereira, Paulo N. G. and Velazquez, Teresa Caballero and Garcia-Calderon, Clara B. and Tharmaratnam, Kukatharmini and Cabral, Ines A. and Ribeiro, Ana C. and Mendes, Laura and Juncal, Clara and Roncon, Susana and Pais, Ana Teresa and Alho, Ana C. and Gil, Alfonso Rodriguez and Espada, Eduardo L. and Rodrigues, Anabela and Garcao, Ana and Yaspo, Marie-Laure and Warnatz, Hans-Joerg and Lehrach, Hans and Barbosa-Morais, Nuno L. and Quintas, Ana Miguel and Palmela, Paulo and Caldas, Cecilia and Ferreira, Rosa and Leite, Luis and Martins, Carlos and Lourenco, Fernanda and Moreno, Raul and Raposo, Joao and Campilho, Fernando and Cheyne, Christopher Paul and Garcia-Finana, Marta and Campos, Antonio and Baron, Frederic and Arpinati, Mario and Edinger, Matthias and Ritz, Jerome and Vaz, Carlos Pinho and Perez-Simon, Jose A. and Lacerda, Joao F. (2022) Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease. In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	05 Sep 2023 05:55
Last Modified:	05 Sep 2023 05:55
URI:	https://pred.uni-regensburg.de/id/eprint/58643

Actions (login required)

View Item